Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: eRM Solutions who wrote (1240)	11/6/1998 6:48:00 PM
From: EZ	Read Replies (3) \| Respond to of 3576

Baxter tried for around 3 years and finally gave up a month or so ago taking a huge loss on the project!I bought mass quanities of puts today when it was {GERN} AT 19....EZ... SHOULD go down steady after small pop at open depending on press over the weekend.JMO

To: eRM Solutions who wrote (1240)	11/6/1998 8:20:00 PM
From: RockyBalboa	Respond to of 3576

Hey, this is good news! BioTime get competitors and copycats. But I seem that SGNC had their double already on the 4th of november. quote.yahoo.com

To: eRM Solutions who wrote (1240)	11/6/1998 11:39:00 PM
From: Prospector	Respond to of 3576

John SGNC is a second generation Synthetic blood,,, That means that the first generation (Fluosol)was FDA approved.. but Green Cross used the product on a patient before it was FDA approved.. falsified some documents and the FDA approval was taken away...later.. and the Patient lived... the Product Fluosol was used on 13,000 patients.. Sanguine Corp second generation product PHER-02 is in animal testing at Battelle Memorial Institute..at the present time..Dr Drees seems to think he can get FDA approval in 3 years or less,, because it has been FDA approved before. Battelle released a news udate a couple of days ago that they have a Major Medical Breakthrough,,, with PHER-02 not only can it be stored at room temperature for a 3 year shelf life,,(while Fluosol had to remain frozen,) It can carry 4 times the amount of Oxygen as a red blood cell and is 1/900 smaller than a red blood cell.. doen't have to be crossed matched,,, one size fits all... completely disease free because it's synthetic... But the major breakthrough is that it now can be disguised from the bodys blood defenses, to where it is not attacked and eaten like all other blood substitutes in the past.. giving it a longer life in the blood...which has been a great problem in the past..... After the mice are tested and this little company comes into the spotlight...it will be bought out by Baxter or one of the other big companys... So this too is on the ground floor... but like other Bio's this is a buy and hold stock.. but this stock is very promising with a 20 billion dollar market, and 150 drug applications... Prospector... Just a thought John...my 2 cents